METHENOLONE ENANTHATE TREN BO LONE ACETATE DROSTANOLONE PROPIONATE
Each ml contains:
Trenbolone Acetate USP100 mg
Drostanolone Propionate 100 mg
MethenoloneEnanthate 50 mg
Miglyol 840, Ethyl oleate. Benzyl benzoate. Benzyl alcohol
Active life: 10 days Detection time: u p to 5 months
CUT 250® is a steroid potent formula an oil based solution mix of 3 compounds: Trenbolone Acetate, Drostanolone Propionate and Methenolone Enanthate for intramuscular injection that producing an anabolic effect and promoting protein synthesis as well as creating positive nitrogen balance in humans.Trenbolone increases protein and decreases fat deposition. It has proven to be an excellent product for promoting size and strength in the presence of adequate protein and calories, promotes body tissue building processes, and can reverse catabolism. High doses of Methenolone Enanthate may stimulate bone marrow function, particularly erythropoiesis.
CUT 250® is a fast-acting injectable steroid compound with a great effect on protein metabolism. Trenbolone is one of the best effective anabolic compounds, promoting protein synthesis, as well as creating a positive nitrogen balance. Methenolone Enanthate is an appetite stimulant and improves the conversion of proteins.ln aplastic anemias of various origins - both the idiopathic forms and those with exogenously damaged bone marrow - high doses of CUT 250® may stimulate bone marrow function, particularly erythropoiesis. Anabolic steroids suppress the gonadotropic functions of the pituitary and may exert a direct effect upon the testes. During exogenous administration of anabolic androgens, endogenous testosterone release is inhibited through inhibition of pituitary luteinizing hormone (LH). At large doses, spermatogenesis may be suppressed through feedback inhibition of pituitary follicle- stimulating hormone (FSH).Drostanolone attaches to androgen receptors; increasing nitrogen retention and protein synthesis. Drostanolone acts on dihydrotestosterone modulated pathways as well.Drostanolone is a potent estrogen antagonist and does not aromatize to estrogen, limiting expression of side effects often linked to estrogen such as water retention, gynecomastia, and some types of high blood pressure. Drostanolone undergoes hepatic metabolism with a half- life of 2-3 days after separation of the ester.
INDICATIONS AND USAGE:
1 .Aplastic anemias. The therapy may have to be continued for at least 3 months at a dosage of 200-300 mg per week. Since some patients only respond after several months, treatment must not be stopped too soon. After improvement of the clinical picture treatment should, as a general rule, be continued for a further few weeks. Deterioration of the blood count after discontinuation of therapy may be reversed by renewed administration of CUT250®
3. Progressive breast cancer
1. Not indicated for women, children, or the elderly.
2. Women who are pregnant or may become pregnant because of possible masculinizationofthe fetus.
3. Patientswith nephrosis orthe nephrotic phase of nephritis.
4. Patientswith hypercalcemia.
5. Patients suffering from testicular cancer, prostate cancer, breast cancer, liver damage, kidney damage, stroke, high blood pressure, heart disease or respiratory problems.
6. Because of this androgenic activity, CUT 250® Injection is also contraindicated in patients with prostatic carcinoma, since such substances may aggravate the disease.
7. CUT 250® is a androgenic hormone and as to be expected there are possible androgenic side effects.Such effects include acne, accelerated hair loss in those predisposed to male pattern baldness, and body hair growth. While such effects are possible they areentirely dependent on yourgenetics.